Skip to main content
Journal cover image

Hospital Readmissions in Patients With Carbapenem-Resistant Klebsiella pneumoniae.

Publication ,  Journal Article
Messina, JA; Cober, E; Richter, SS; Perez, F; Salata, RA; Kalayjian, RC; Watkins, RR; Scalera, NM; Doi, Y; Kaye, KS; Evans, S; Bonomo, RA ...
Published in: Infect Control Hosp Epidemiol
March 2016

BACKGROUND: Various transmission routes contribute to spread of carbapenem-resistant Klebsiella pneumoniae (CRKP) in hospitalized patients. Patients with readmissions during which CRKP is again isolated ("CRKP readmission") potentially contribute to transmission of CRKP. OBJECTIVE: To evaluate CRKP readmissions in the Consortium on Resistance against Carbapenems in K. pneumoniae (CRaCKLe). DESIGN: Cohort study from December 24, 2011, through July 1, 2013. SETTING: Multicenter consortium of acute care hospitals in the Great Lakes region. PATIENTS: All patients who were discharged alive during the study period were included. Each patient was included only once at the time of the first CRKP-positive culture. METHODS: All readmissions within 90 days of discharge from the index hospitalization during which CRKP was again found were analyzed. Risk factors for CRKP readmission were evaluated in multivariable models. RESULTS: Fifty-six (20%) of 287 patients who were discharged alive had a CRKP readmission. History of malignancy was associated with CRKP readmission (adjusted odds ratio [adjusted OR], 3.00 [95% CI, 1.32-6.65], P<.01). During the index hospitalization, 160 patients (56%) received antibiotic treatment against CRKP; the choice of regimen was associated with CRKP readmission (P=.02). Receipt of tigecycline-based therapy (adjusted OR, 5.13 [95% CI, 1.72-17.44], using aminoglycoside-based therapy as a reference in those treated with anti-CRKP antibiotics) was associated with CRKP readmission. CONCLUSION: Hospitalized patients with CRKP-specifically those with a history of malignancy-are at high risk of readmission with recurrent CRKP infection or colonization. Treatment during the index hospitalization with a tigecycline-based regimen increases this risk.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Infect Control Hosp Epidemiol

DOI

EISSN

1559-6834

Publication Date

March 2016

Volume

37

Issue

3

Start / End Page

281 / 288

Location

United States

Related Subject Headings

  • beta-Lactam Resistance
  • United States
  • Tigecycline
  • Risk Factors
  • Prospective Studies
  • Patient Readmission
  • Odds Ratio
  • Multivariate Analysis
  • Minocycline
  • Middle Aged
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Messina, J. A., Cober, E., Richter, S. S., Perez, F., Salata, R. A., Kalayjian, R. C., … Antibacterial Resistance Leadership Group, . (2016). Hospital Readmissions in Patients With Carbapenem-Resistant Klebsiella pneumoniae. Infect Control Hosp Epidemiol, 37(3), 281–288. https://doi.org/10.1017/ice.2015.298
Messina, Julia A., Eric Cober, Sandra S. Richter, Federico Perez, Robert A. Salata, Robert C. Kalayjian, Richard R. Watkins, et al. “Hospital Readmissions in Patients With Carbapenem-Resistant Klebsiella pneumoniae.Infect Control Hosp Epidemiol 37, no. 3 (March 2016): 281–88. https://doi.org/10.1017/ice.2015.298.
Messina JA, Cober E, Richter SS, Perez F, Salata RA, Kalayjian RC, et al. Hospital Readmissions in Patients With Carbapenem-Resistant Klebsiella pneumoniae. Infect Control Hosp Epidemiol. 2016 Mar;37(3):281–8.
Messina, Julia A., et al. “Hospital Readmissions in Patients With Carbapenem-Resistant Klebsiella pneumoniae.Infect Control Hosp Epidemiol, vol. 37, no. 3, Mar. 2016, pp. 281–88. Pubmed, doi:10.1017/ice.2015.298.
Messina JA, Cober E, Richter SS, Perez F, Salata RA, Kalayjian RC, Watkins RR, Scalera NM, Doi Y, Kaye KS, Evans S, Bonomo RA, Fowler VG, van Duin D, Antibacterial Resistance Leadership Group. Hospital Readmissions in Patients With Carbapenem-Resistant Klebsiella pneumoniae. Infect Control Hosp Epidemiol. 2016 Mar;37(3):281–288.
Journal cover image

Published In

Infect Control Hosp Epidemiol

DOI

EISSN

1559-6834

Publication Date

March 2016

Volume

37

Issue

3

Start / End Page

281 / 288

Location

United States

Related Subject Headings

  • beta-Lactam Resistance
  • United States
  • Tigecycline
  • Risk Factors
  • Prospective Studies
  • Patient Readmission
  • Odds Ratio
  • Multivariate Analysis
  • Minocycline
  • Middle Aged